mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice

Ken Inoki, Hiroyuki Mori, Junying Wang, Tsukasa Suzuki, SungKi Hong, Sei Yoshida, Simone M. Blattner, Tsuneo Ikenoue, Markus A. Rüegg, Michael N. Hall, David J. Kwiatkowski, Maria P. Rastaldi, Tobias B. Huber, Matthias Kretzler, Lawrence B. Holzman, Roger C. Wiggins, Kun Liang Guan

Research output: Contribution to journalArticle

301 Citations (Scopus)

Abstract

Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocytespecific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalization of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.

Original languageEnglish
Pages (from-to)2181-2196
Number of pages16
JournalJournal of Clinical Investigation
Volume121
Issue number6
DOIs
Publication statusPublished - Jun 1 2011

Fingerprint

Podocytes
Diabetic Nephropathies
Proteinuria
Glomerular Basement Membrane
Epithelial-Mesenchymal Transition
Diaphragm
Young Adult
Phosphotransferases
Food

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., ... Guan, K. L. (2011). mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. Journal of Clinical Investigation, 121(6), 2181-2196. https://doi.org/10.1172/JCI44771

mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. / Inoki, Ken; Mori, Hiroyuki; Wang, Junying; Suzuki, Tsukasa; Hong, SungKi; Yoshida, Sei; Blattner, Simone M.; Ikenoue, Tsuneo; Rüegg, Markus A.; Hall, Michael N.; Kwiatkowski, David J.; Rastaldi, Maria P.; Huber, Tobias B.; Kretzler, Matthias; Holzman, Lawrence B.; Wiggins, Roger C.; Guan, Kun Liang.

In: Journal of Clinical Investigation, Vol. 121, No. 6, 01.06.2011, p. 2181-2196.

Research output: Contribution to journalArticle

Inoki, K, Mori, H, Wang, J, Suzuki, T, Hong, S, Yoshida, S, Blattner, SM, Ikenoue, T, Rüegg, MA, Hall, MN, Kwiatkowski, DJ, Rastaldi, MP, Huber, TB, Kretzler, M, Holzman, LB, Wiggins, RC & Guan, KL 2011, 'mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice', Journal of Clinical Investigation, vol. 121, no. 6, pp. 2181-2196. https://doi.org/10.1172/JCI44771
Inoki, Ken ; Mori, Hiroyuki ; Wang, Junying ; Suzuki, Tsukasa ; Hong, SungKi ; Yoshida, Sei ; Blattner, Simone M. ; Ikenoue, Tsuneo ; Rüegg, Markus A. ; Hall, Michael N. ; Kwiatkowski, David J. ; Rastaldi, Maria P. ; Huber, Tobias B. ; Kretzler, Matthias ; Holzman, Lawrence B. ; Wiggins, Roger C. ; Guan, Kun Liang. / mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. In: Journal of Clinical Investigation. 2011 ; Vol. 121, No. 6. pp. 2181-2196.
@article{1906fbac7c3d4221a04994214e23d566,
title = "mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice",
abstract = "Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocytespecific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalization of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.",
author = "Ken Inoki and Hiroyuki Mori and Junying Wang and Tsukasa Suzuki and SungKi Hong and Sei Yoshida and Blattner, {Simone M.} and Tsuneo Ikenoue and R{\"u}egg, {Markus A.} and Hall, {Michael N.} and Kwiatkowski, {David J.} and Rastaldi, {Maria P.} and Huber, {Tobias B.} and Matthias Kretzler and Holzman, {Lawrence B.} and Wiggins, {Roger C.} and Guan, {Kun Liang}",
year = "2011",
month = "6",
day = "1",
doi = "10.1172/JCI44771",
language = "English",
volume = "121",
pages = "2181--2196",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice

AU - Inoki, Ken

AU - Mori, Hiroyuki

AU - Wang, Junying

AU - Suzuki, Tsukasa

AU - Hong, SungKi

AU - Yoshida, Sei

AU - Blattner, Simone M.

AU - Ikenoue, Tsuneo

AU - Rüegg, Markus A.

AU - Hall, Michael N.

AU - Kwiatkowski, David J.

AU - Rastaldi, Maria P.

AU - Huber, Tobias B.

AU - Kretzler, Matthias

AU - Holzman, Lawrence B.

AU - Wiggins, Roger C.

AU - Guan, Kun Liang

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocytespecific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalization of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.

AB - Diabetic nephropathy (DN) is among the most lethal complications that occur in type 1 and type 2 diabetics. Podocyte dysfunction is postulated to be a critical event associated with proteinuria and glomerulosclerosis in glomerular diseases including DN. However, molecular mechanisms of podocyte dysfunction in the development of DN are not well understood. Here we have shown that activity of mTOR complex 1 (mTORC1), a kinase that senses nutrient availability, was enhanced in the podocytes of diabetic animals. Further, podocytespecific mTORC1 activation induced by ablation of an upstream negative regulator (PcKOTsc1) recapitulated many DN features, including podocyte loss, glomerular basement membrane thickening, mesangial expansion, and proteinuria in nondiabetic young and adult mice. Abnormal mTORC1 activation caused mislocalization of slit diaphragm proteins and induced an epithelial-mesenchymal transition-like phenotypic switch with enhanced ER stress in podocytes. Conversely, reduction of ER stress with a chemical chaperone significantly protected against both the podocyte phenotypic switch and podocyte loss in PcKOTsc1 mice. Finally, genetic reduction of podocyte-specific mTORC1 in diabetic animals suppressed the development of DN. These results indicate that mTORC1 activation in podocytes is a critical event in inducing DN and suggest that reduction of podocyte mTORC1 activity is a potential therapeutic strategy to prevent DN.

UR - http://www.scopus.com/inward/record.url?scp=79957927211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957927211&partnerID=8YFLogxK

U2 - 10.1172/JCI44771

DO - 10.1172/JCI44771

M3 - Article

C2 - 21606597

AN - SCOPUS:79957927211

VL - 121

SP - 2181

EP - 2196

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -